Simon Quick Advisors LLC Takes $241,000 Position in Relx Plc (NYSE:RELX)

Simon Quick Advisors LLC purchased a new stake in Relx Plc (NYSE:RELX - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,779 shares of the technology company's stock, valued at approximately $241,000.

Other large investors have also modified their holdings of the company. Transce3nd LLC acquired a new stake in shares of Relx in the fourth quarter valued at approximately $40,000. Sierra Ocean LLC acquired a new stake in shares of Relx in the fourth quarter valued at approximately $43,000. Brown Brothers Harriman & Co. grew its position in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares during the last quarter. Private Trust Co. NA grew its position in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares during the last quarter. Finally, Whipplewood Advisors LLC acquired a new stake in shares of Relx in the fourth quarter valued at approximately $74,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Stock Performance

Shares of RELX opened at $52.73 on Monday. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market capitalization of $97.34 billion, a price-to-earnings ratio of 28.35, a PEG ratio of 2.73 and a beta of 0.84. The company's 50 day simple moving average is $53.13 and its 200 day simple moving average is $49.99. Relx Plc has a 1 year low of $43.45 and a 1 year high of $56.33.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on RELX shares. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group initiated coverage on shares of Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.